Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    INFLAMMATORY BOWEL DISEASE 24
Show Display Options
Rank Status Study
1 Completed A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)
Condition: Crohn's Disease
Intervention: Drug: Certolizumab Pegol (CDP870)
2 Recruiting Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease
Condition: Crohn's Disease
Interventions: Other: Cx601;   Other: Saline solution
3 Completed Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).
Condition: Crohn's Disease
Intervention: Drug: Certolizumab Pegol (CDP870)
4 Completed Canadian Active & Maintenance Modified Pentasa Study
Conditions: Active Ulcerative Colitis;   Remission of Ulcerative Colitis
Intervention: Drug: 5-ASA (5-Aminosalicylate)

Indicates status has not been verified in more than two years